Current Status
Not Enrolled
Price
$49.99
Get Started

Course

Malignant Brain Tumor Review

Contact Hours Awarded: 2

Start Course
Now

Course Overview

Malignant Brain Tumor Review

Author: R.E. Hengsterman MSN, RN 

This course offers an in-depth exploration of malignant brain tumors, their etiology, diagnosis, and advanced treatment approaches. Focusing on aggressive cancers like glioblastomas, astrocytomas, and ependymomas, learners will gain a comprehensive understanding of how these tumors arise from genetic mutations disrupting cell regulation. The course will cover primary versus metastatic brain tumors, emphasizing the World Health Organization (WHO) grading system and its significance in guiding treatment decisions. In addition, the course delves into current and emerging treatment modalities, including advanced surgical techniques, precision radiation therapies, immunotherapy, and gene-based approaches aimed at reducing recurrence and improving patient outcomes.  

Course Outline

  1. Introduction 
  2. Primary Brain Tumors 
  3. Metastatic Brain Tumors 
  4. Tumor Staging 
  5. Symptomology 
  6. Other Types of Brain Tumors 
  7. Incidence of Brain Tumors 
  8. Causes 
  9. Diagnostic 
  10. Treatment and Care 

Accreditation Statement

Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In this course, we will discuss Malignant Brain Tumor Review. It will take the average learner 120 minutes to complete and awards 2 contact hours of continuing education.

Course Outcomes

After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:

  1. Discuss the cellular mechanisms underlying malignant brain tumors,  
  2. Recognize contributing factors including tumor location, growth rate, and surrounding brain structures influence the presentation of symptoms. 
  3. Explore various treatment modalities, including surgery, radiation, chemotherapy, and emerging therapies like cell-based and gene therapies.  

Target Audience

  • Registered Nurses (RN)
  • Advanced Practice Registered Nurses (APRN)
  • Licensed Practical Nurses (LPN/LVN)

Requirement for Completion

  1. Enrollment in the course by the learner
  2. Read and learn all course materials
  3. Complete the course evaluation
  4. Attest and testify learning of the course materials

Accreditations + Approvals

  • American Nurses Credentialing Center (ANCC) (P0614)
  • California Board of Registered Nursing (CEP 17418)
  • Kentucky Board of Nursing (7-0090)
  • Louisiana State Board of Nursing (58)
  • New York State Department of Education (IC 208)
  • New York State Department of Education Child Abuse #80996
  • Florida Board of Nursing (50-23983)

Disclosure of Relevant Financial Relationships

Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.

Start Course
Now

Course created on: January 28, 2025

Course Expires on: January 28, 2028

Course Offering: #639